Navigating Cancer Care Costs VL

Understanding Time Toxicity: Impact of Treatment Time on Prostate Cancer Patients - Daniel Sentana Lledo

Details
Ruchika Talwar hosts Daniel Sentana Lledo to discuss the concept of time toxicity in prostate cancer treatment. Time toxicity measures the amount of time patients spend in the healthcare system and how it impacts their survival time gained from therapies. The conversation explores how even simple clinic visits for lab work or imaging can take around two hours, with additional time spent on transpo...

CEASAR Study Highlights Quality of Life Outcomes in Prostate Cancer Treatment - Bashir Al Hussein Al Awamlh

Details
Ruchika Talwar speaks with Bashir Al Hussein Al Awamlh about quality of life considerations in prostate cancer treatment decision-making. The discussion focuses on the importance of shared decision-making and findings from the CEASAR study, which examines quality of life outcomes across different treatment modalities including surgery, radiation, and active surveillance. Dr. Al Hussein highlights...

Advanced Prostate Cancer Treatment Cost Analysis and Patient Impact in the VA Healthcare System - Daniel Lee

Details
Daniel Lee discusses patient-facing costs for advanced prostate cancer treatment within the VA Health Care System. The conversation explores how recent legislation and VA programs, including the Cleland-Dole Act of 2022, have improved access to care through initiatives like the National Tele-Oncology Program and Precision Oncology Program. While the VA system offers significant advantages with low...

Medicare Part D 2025 Reduces Out-of-Pocket Costs for Oral Prostate Cancer Treatments - David Morris

Details
Ruchika Talwar interviews David Morris about changes in 2025 for Medicare Part D resulting from the Inflation Reduction Act (IRA). Dr. Morris discusses how these changes benefit prostate cancer patients and all Medicare recipients who have Medicare Part D coverage. This Medicare change reduces the out-of-pocket expenses for prescription drugs paid by Part D plans. Key points include the introducti...

Financial Distress for GU Cancer Patients: Insights from CDC Survey - Laura Bukavina & Steven Leonard

Details
Ruchika Talwar interviews Laura Bukavina and Steven Leonard about their study on financial distress for genitourinary cancer patients. Using data from the CDC National Health Interview Survey, they explore how the rising costs of cancer drugs impact patients' financial well-being and access to care. The study reveals that GU cancer patients, particularly those with bladder and kidney cancer, strug...

Cancer-Related Financial Hardship Among Cancer Survivors: Research from the HINTS-SEER Survey - Apoorv Dhir & Rishi Sekar

Details
Ruchika Talwar interviews Apoorv Dhir and Rishi Sekar about their study on cancer-related financial hardship among cancer survivors. The researchers discuss findings from the HINTS-SEER survey, which reveals that 44% of cancer patients report some level of financial hardship. They highlight the importance of considering both individual and community-level factors in assessing financial burden. The...

Advanced Prostate Cancer: Understanding Out-of-Pocket Medication Costs - Daniel Joyce

Details
Daniel Joyce discusses the financial impact of advanced prostate cancer treatments on patients. He presents research showing significant out-of-pocket costs for oral cancer therapies, particularly for commercially insured patients. Dr. Joyce highlights disparities in costs based on factors like age, race, and income. He emphasizes the importance of addressing financial toxicity in patient care, no...

Reducing Prescription Drug Costs: 4 Online Tools for Urology Patients - Benjamin Pockros

Details
Ruchika Talwar interviews Benjamin Pockros about his published work in Urology Practice, which explores online tools to reduce financial toxicity for urology patients. Dr. Pockros presents a framework of four key tools: Medicare Part D Plan Finder, GoodRx, Mark Cuban Cost Plus Drugs Company, and Amazon Pharmacy. They discuss how each tool can be applied to different patient scenarios, emphasizing...